ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026)
ARS Pharmaceuticals (SPRY) posted Change in Inventory of $294000.0 for Q1 2026, down 96.97% sequentially from $9.7 million in Q4 2025, and down 96.52% YoY from $8.4 million in Q1 2025.
ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026) Analysis & Trends
ARS Pharmaceuticals has reported Change in Inventory for 3 years, with the latest figure at $294000.0 in Q1 2026.
- Quarterly Change in Inventory fell 96.52% year-over-year to $294000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (down 3.91% YoY) and the FY2025 annual result came in at $22.0 million, up 269.82% from the prior year.
- Change in Inventory fell to $294000.0 in Q1 2026 per SPRY's latest filing, from $9.7 million in the prior quarter.
- Over five years, Change in Inventory peaked at $9.7 million in Q4 2025 and troughed at -$963000.0 in Q3 2025.
- A 3-year average of $4.0 million and a median of $4.8 million in 2025 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 68.64% in 2025, down 626.23% in 2025.
- Over 3 years, Change in Inventory stood at $5.8 million in 2024, then jumped by 68.64% to $9.7 million in 2025, then slumped by 96.97% to $294000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $294000.0, $9.7 million, and -$963000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13,000.00 |
| Jun 30, 2026 | -13,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 9.72 Mn |
| Dec 31, 2025 | 9.72 Mn |
| Sep 30, 2025 | -963,000.00 |
| Sep 30, 2025 | -963,000.00 |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Dec 31, 2024 | 5.76 Mn |
| Dec 31, 2024 | 5.76 Mn |
| Sep 30, 2024 | 183,000.00 |
| Sep 30, 2024 | 183,000.00 |